Russell Investments Group’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$254K Sell
14,924
-14,305
-49% -$243K ﹤0.01% 2579
2025
Q1
$571K Sell
29,229
-146,952
-83% -$2.87M ﹤0.01% 2256
2024
Q4
$4.37M Sell
176,181
-11,664
-6% -$289K 0.01% 1237
2024
Q3
$4.6M Buy
187,845
+18,284
+11% +$448K 0.01% 1233
2024
Q2
$3.97M Buy
169,561
+25,733
+18% +$603K 0.01% 1263
2024
Q1
$4.75M Buy
143,828
+6,102
+4% +$202K 0.01% 1194
2023
Q4
$3.75M Buy
137,726
+115
+0.1% +$3.13K 0.01% 1279
2023
Q3
$3.31M Buy
137,611
+21,251
+18% +$511K 0.01% 1280
2023
Q2
$3.72M Buy
116,360
+7,602
+7% +$243K 0.01% 1220
2023
Q1
$3.33M Buy
108,758
+17,496
+19% +$536K 0.01% 1295
2022
Q4
$3.57M Sell
91,262
-799
-0.9% -$31.2K 0.01% 1264
2022
Q3
$4.38M Buy
92,061
+1,849
+2% +$88.1K 0.01% 1126
2022
Q2
$3.49M Sell
90,212
-8
-0% -$310 0.01% 1280
2022
Q1
$5.17M Buy
90,220
+894
+1% +$51.2K 0.01% 1139
2021
Q4
$7.12M Buy
89,326
+18,303
+26% +$1.46M 0.01% 1066
2021
Q3
$6.18M Buy
71,023
+10,106
+17% +$879K 0.01% 1128
2021
Q2
$7.84M Buy
60,917
+33,537
+122% +$4.32M 0.01% 1067
2021
Q1
$2.19M Buy
27,380
+21,565
+371% +$1.72M ﹤0.01% 1830
2020
Q4
$474K Buy
+5,815
New +$474K ﹤0.01% 2453